Skip to content
healthcare.dev
Get a free key

Morning After

NDC 69953-516, Levonorgestrel, tablet, from Rapha Pharmaceuticals, Inc..

Product NDC
69953-516
Status
Listed
Labeler
Rapha Pharmaceuticals, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA205329
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69953-516 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LEVONORGESTREL1.5 mg/1.5mg

Pharmacologic classes

Inhibit Ovum Fertilization [PE]; Progesterone Congeners [CS]; Progesterone Congeners [CS]; Progestin [EPC]; Progestin-containing Intrauterine Device [EPC]

Package NDCNDC-11Package
69953-516-01699530516011 BLISTER PACK in 1 CARTON (69953-516-01) / 1 mg in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 69953-516 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69953-516 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69953-516. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.